EUObserver reports that the European Medicines Agency has reversed its long-held stance on releasing studies on drug side effects after pressure from the European Ombudsman. The London-based agency, which evaluates drugs in the EU, on Wednesday (11 August) said that it would issue data on anti-acne medication Roaccutane produced by pharma giant Roche in the coming weeks.
Read more here: http://euobserver.com/9/30613/?rk=1
The Irish Backdoor
-
It’s not a gay bar in Dublin, the Irish Backdoor, sorry if that’s why you
clicked on this blog. It’s how non-EU companies, like tech companies from
the ...
1 day ago
No comments:
Post a Comment